{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:17:25Z","timestamp":1783397845051,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101158","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:08:08Z","timestamp":1775495288000},"page":"101158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9552-316X","authenticated-orcid":false,"given":"Perla","family":"Zidane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3747-2234","authenticated-orcid":false,"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6077-7610","authenticated-orcid":false,"given":"Angela","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela","family":"Caraivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5979-7542","authenticated-orcid":false,"given":"Mazen","family":"Moussallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Udrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101158_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2026.101158_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-022-02043-y","article-title":"Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review","volume":"22","author":"Petersen","year":"2022","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ctro.2026.101158_b0015","first-page":"298","volume":"26","author":"Chargari","year":"2022","journal-title":"Radiotherapy of Cervical Cancer Cancer\/radioth\u00e9rapie"},{"key":"10.1016\/j.ctro.2026.101158_b0020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0025","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0030","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101158_b0035","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5374","article-title":"Promising predictive molecular biomarkers for cervical cancer (Review)","volume":"53","author":"Lizano","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ctro.2026.101158_b0040","article-title":"Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0045","article-title":"Effect of radiotherapy on the survival of cervical cancer patients: an analysis based on SEER database","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ctro.2026.101158_b0050","article-title":"The research progress on radiation resistance of cervical cancer","volume":"14","author":"Liang","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0055","doi-asserted-by":"crossref","first-page":"L41","DOI":"10.1088\/1361-6560\/aa9517","article-title":"First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment","volume":"62","author":"Raaymakers","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2026.101158_b0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2018.06.014","article-title":"Tumor Shrinkage during Chemoradiation in locally Advanced Cervical Cancer patients: Prognostic significance, and Impact for Image-Guided Adaptive Brachytherapy","volume":"102","author":"Schernberg","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1533034615573796","article-title":"Kinetic Models for predicting Cervical Cancer Response to Radiation Therapy on Individual Basis using Tumor Regression measured In Vivo with Volumetric Imaging","volume":"15","author":"Belfatto","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ctro.2026.101158_b0070","article-title":"The Prognostic Value of Tumor size, volume and Tumor volume Reduction Rate during concurrent Chemoradiotherapy in patients with Cervical Cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0075","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.3390\/jcm9113471","article-title":"Prognostic significance of Tumor Regression Rate during concurrent Chemoradiotherapy in locally Advanced Cervix Cancer: Analysis by Radiation phase and Histologic Type","volume":"9","author":"Kang","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ctro.2026.101158_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1366777","article-title":"The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer","volume":"14","author":"Ohtaka","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13014-025-02623-w","article-title":"Prognostic implications of tumor volume reduction during radiotherapy in locally advanced cervical cancer: a risk-stratified analysis","volume":"20","author":"Lin","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2021.04.001","article-title":"Evolution of the gross tumour volume extent during radiotherapy for glioblastomas","volume":"160","author":"Bernchou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.radonc.2018.06.019","article-title":"A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer","volume":"128","author":"Fiorino","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ijrobp.2020.07.2323","article-title":"External Validation of Early Regression Index (ERITCP) as Predictor of Pathologic complete Response in Rectal Cancer using magnetic Resonance-Guided Radiation Therapy","volume":"108","author":"Cusumano","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0105","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3390\/cancers15123071","article-title":"The Role of Multimodal Imaging in Pathological Response Prediction of locally Advanced Cervical Cancer patients Treated by Chemoradiation Therapy Followed by Radical Surgery","volume":"15","author":"Pasciuto","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctro.2026.101158_b0110","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1245\/s10434-022-11583-4","article-title":"Clinical Impact of Pathologic Residual Tumor in locally Advanced Cervical Cancer patients managed by Chemoradiotherapy Followed by Radical Surgery: a Large, Multicenter","volume":"29","author":"Federico","year":"2022","journal-title":"Retrospective Study Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-022-01981-z","article-title":"MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience","volume":"17","author":"Hadi","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0120","article-title":"Adaptive magnetic Resonance-Guided External Beam Radiation Therapy for consolidation in Recurrent Cervical Cancer","volume":"7","author":"Felici","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clon.2023.11.036","article-title":"Online Adaptive magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary results of Feasibility and Outcome","volume":"36","author":"Ugurluer","year":"2024","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101158_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110263","article-title":"MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy","volume":"195","author":"Skipar","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:39:50Z","timestamp":1783395590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S2405630826000534"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101158","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101158"}}